2-Amino-3-(2-fluoro-3,4-dihydroxyphenyl)propanoic acid (BioDeep_00000174926)
human metabolite blood metabolite
代谢物信息卡片
2-Amino-3-(2-fluoro-3,4-dihydroxyphenyl)propanoic acid
化学式: C9H10FNO4 (215.0593832)
中文名称:
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: C1=CC(=C(C(=C1CC(C(=O)O)N)F)O)O
InChI: InChI=1S/C9H10FNO4/c10-7-4(3-5(11)9(14)15)1-2-6(12)8(7)13/h1-2,5,12-13H,3,11H2,(H,14,15)
描述信息
同义名列表
14 个代谢物同义名
2-Amino-3-(2-fluoro-3,4-dihydroxyphenyl)propanoic acid; 2-Amino-3-(2-fluoro-3,4-dihydroxyphenyl)propanoate; 3-(2-Fluoro-(18)F-4,5-dihydroxyphenyl)-L-alanine; 6-(18F)Fluoro-L-3,4-dihydroxyphenylalanine; 3,4-Dihydroxy-6-fluorophenylalanine; Fluorodopa F 18, (18)F-labeled CPD; 2-Fluoro-5-hydroxytyrosine; 6-(18F)Fluoro-L-dopa; Fluorodopa F-18; Fluorodopa F 18; 6-Fluoro-dopa; Fluorodopa; (18)F-Dopa; 18F-FDOPA
数据库引用编号
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
1 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Jacopo Manso, Loris Bertazza, Susi Barollo, Alberto Mondin, Simona Censi, Sofia Carducci, Alfonso Massimiliano Ferrara, Isabella Merante Boschin, Stefania Zovato, Francesca Schiavi, Michele Gregianin, Gianmaria Pennelli, Maurizio Iacobone, Caterina Mian. Overexpression of miR-375 and L-type Amino Acid Transporter 1 in Pheochromocytoma and Their Molecular and Functional Implications.
International journal of molecular sciences.
2022 Feb; 23(5):. doi:
10.3390/ijms23052413. [PMID: 35269556] - M Y Zhang, J W Ni, J J Ge, Y H Guan, Z Pei, C J Sun, J Wu, Z R Xu, L Yang, F H Luo, R Q Cheng. [Clinical features of 123 patients with hyperinsulinemic hypoglycemia auxiliarily diagnosed by 18F-DOPA-PET CT scanning].
Zhonghua er ke za zhi = Chinese journal of pediatrics.
2021 Oct; 59(10):853-858. doi:
10.3760/cma.j.cn112140-20210417-00326. [PMID: 34587682] - Marie Terroir, Caroline Caramella, Isabelle Borget, Sophie Bidault, Clarisse Dromain, Khadija El Farsaoui, Désirée Deandreis, Serena Grimaldi, Jean Lumbroso, Amandine Berdelou, Julien Hadoux, Segolene Hescot, Dana Hartl, Eric Baudin, Martin Schlumberger, Sophie Leboulleux. F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients.
Thyroid : official journal of the American Thyroid Association.
2019 10; 29(10):1457-1464. doi:
10.1089/thy.2018.0351. [PMID: 31530235] - Jinwen Ni, Jingjie Ge, Miaoying Zhang, Khalid Hussain, Yihui Guan, Ruoqian Cheng, Li Xi, Zhangqian Zheng, Shuhua Ren, Feihong Luo. Genotype and phenotype analysis of a cohort of patients with congenital hyperinsulinism based on DOPA-PET CT scanning.
European journal of pediatrics.
2019 Aug; 178(8):1161-1169. doi:
10.1007/s00431-019-03408-6. [PMID: 31218401] - Zyrafete Kuçi, Walter Ehrlichmann, Jörg Sauer, Rupert Handgretinger, Gernot Bruchelt, Gerald Reischl. Fast enzymatic synthesis of n.c.a. 6-[18 F]fluorodopamine (FDA) from n.c.a. 6-[18 F]FDOPA and the fate of 6-FDOPA and 6-FDA in neuroblastoma and Caki-1 cells after their uptake.
Journal of labelled compounds & radiopharmaceuticals.
2019 06; 62(8):438-447. doi:
10.1002/jlcr.3752. [PMID: 31090094] - Sazan Rasul, Sabrina Hartenbach, Katharina Rebhan, Adelina Göllner, Georgios Karanikas, Marius Mayerhoefer, Peter Mazal, Marcus Hacker, Markus Hartenbach. [18F]DOPA PET/ceCT in diagnosis and staging of primary medullary thyroid carcinoma prior to surgery.
European journal of nuclear medicine and molecular imaging.
2018 11; 45(12):2159-2169. doi:
10.1007/s00259-018-4045-9. [PMID: 29766245] - Deep K Hathi, Elizabeth N DeLassus, Samuel Achilefu, Jonathan McConathy, Monica Shokeen. Imaging Melphalan Therapy Response in Preclinical Extramedullary Multiple Myeloma with 18F-FDOPA and 18F-FDG PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2018 10; 59(10):1551-1557. doi:
10.2967/jnumed.118.208744. [PMID: 29700126] - Vincent Amodru, Carole Guerin, Sarkis Delcourt, Pauline Romanet, Anderson Loundou, Bruna Viana, Thierry Brue, Frédéric Castinetti, Frédéric Sebag, Karel Pacak, David Taïeb. Quantitative 18F-DOPA PET/CT in pheochromocytoma: the relationship between tumor secretion and its biochemical phenotype.
European journal of nuclear medicine and molecular imaging.
2018 Feb; 45(2):278-282. doi:
10.1007/s00259-017-3833-y. [PMID: 28918451] - Sophie Moog, Sébastien Houy, Elodie Chevalier, Stéphane Ory, Georges Weryha, Marion Rame, Marc Klein, Laurent Brunaud, Stéphane Gasman, Thomas Cuny. 18F-FDOPA PET/CT Uptake Parameters Correlate with Catecholamine Secretion in Human Pheochromocytomas.
Neuroendocrinology.
2018; 107(3):228-236. doi:
10.1159/000491578. [PMID: 29949805] - Federico Caobelli, Agostino Chiaravalloti, Laura Evangelista, Giorgio Saladini, Orazio Schillaci, Manuela Vadrucci, Federica Scalorbi, Davide Donner, Pierpaolo Alongi. Predictive and prognostic value of 18F-DOPA PET/CT in patients affected by recurrent medullary carcinoma of the thyroid.
Annals of nuclear medicine.
2018 Jan; 32(1):7-15. doi:
10.1007/s12149-017-1213-0. [PMID: 28986764] - Bing Zhang, Qiao He, Xinchong Shi, Xiaoyan Wang, Xiangsong Zhang. Recurrent Scapular Metastasis From Hepatoblastoma Shown on FDG PET/CT and F-DOPA PET/CT.
Clinical nuclear medicine.
2017 Oct; 42(10):e449-e451. doi:
10.1097/rlu.0000000000001786. [PMID: 28806258] - Daryl J Wile, Pankaj A Agarwal, Michael Schulzer, Edwin Mak, Katherine Dinelle, Elham Shahinfard, Nasim Vafai, Kazuko Hasegawa, Jing Zhang, Jessamyn McKenzie, Nicole Neilson, Audrey Strongosky, Ryan J Uitti, Mark Guttman, Cyrus P Zabetian, Yu-Shin Ding, Mike Adam, Jan Aasly, Zbigniew K Wszolek, Matthew Farrer, Vesna Sossi, A Jon Stoessl. Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies.
The Lancet. Neurology.
2017 05; 16(5):351-359. doi:
10.1016/s1474-4422(17)30056-x. [PMID: 28336296] - Adriana Trapani, Domenico Tricarico, Antonietta Mele, Fatima Maqoud, Delia Mandracchia, Paola Vitale, Vito Capriati, Giuseppe Trapani, Vincenzo Dimiccoli, Anna Tolomeo, Antonio Scilimati. A novel injectable formulation of 6-fluoro-l-DOPA imaging agent for diagnosis of neuroendocrine tumors and Parkinson's disease.
International journal of pharmaceutics.
2017 Mar; 519(1-2):304-313. doi:
10.1016/j.ijpharm.2017.01.038. [PMID: 28119123] - Céline Heimburger, Gerlinde Averous, Emmanuelle Charlin, Hervé Lang, Jean-Emmanuel Kurtz, Alessio Imperiale. Adrenal Metastasis of a Poorly Differentiated Adenocarcinoma Mimicking a Pheochromocytoma on 18F-FDOPA PET/CT.
Clinical nuclear medicine.
2016 Sep; 41(9):691-2. doi:
10.1097/rlu.0000000000001299. [PMID: 27355847] - Piyaratana Tosukhowong, Chanchai Boonla, Thasinas Dissayabutra, Lalita Kaewwilai, Sasipa Muensri, Chanisa Chotipanich, Juho Joutsa, Juha Rinne, Roongroj Bhidayasiri. Biochemical and clinical effects of Whey protein supplementation in Parkinson's disease: A pilot study.
Journal of the neurological sciences.
2016 Aug; 367(?):162-70. doi:
10.1016/j.jns.2016.05.056. [PMID: 27423583] - Aurélien Archier, Céline Heimburger, Carole Guerin, Isabelle Morange, Fausto F Palazzo, Jean-François Henry, Olivier Schneegans, Olivier Mundler, Ahmad Esmaeel Abdullah, Frédéric Sebag, Alessio Imperiale, David Taïeb. (18)F-DOPA PET/CT in the diagnosis and localization of persistent medullary thyroid carcinoma.
European journal of nuclear medicine and molecular imaging.
2016 Jun; 43(6):1027-33. doi:
10.1007/s00259-015-3227-y. [PMID: 26497699] - Masakatsu Kanazawa, Hiroyuki Ohba, Norihiro Harada, Takeharu Kakiuchi, Shin-Ichi Muramatsu, Hideo Tsukada. Evaluation of 6-11C-Methyl-m-Tyrosine as a PET Probe for Presynaptic Dopaminergic Activity: A Comparison PET Study with β-11C-l-DOPA and 18F-FDOPA in Parkinson Disease Monkeys.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2016 Feb; 57(2):303-8. doi:
10.2967/jnumed.115.161802. [PMID: 26564319] - Nunzia Cinzia Paladino, Aoife Lowery, Carole Guérin, David Taïeb, Frédéric Sebag. Multimodality imaging of bilateral pheochromocytoma. A case report.
Annali italiani di chirurgia.
2015 Jun; 86(ePub):. doi:
NULL. [PMID: 26208532] - Mario Riverol, Cristina Ordóñez, María Collantes, Carla DiCaudo, Iván Peñuelas, Javier Arbizu, Irene Marcilla, María R Luquin. Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway.
Neurobiology of disease.
2014 Feb; 62(?):250-9. doi:
10.1016/j.nbd.2013.09.014. [PMID: 24076099] - Maria Cristina Marzola, Sotirios Chondrogiannis, Gaia Grassetto, Lucia Rampin, Anna Margherita Maffione, Alice Ferretti, Giuseppe Opocher, Francesca Schiavi, Patrick M Colletti, Domenico Rubello. 18F-DOPA PET/CT in the evaluation of hereditary SDH-deficiency paraganglioma-pheochromocytoma syndromes.
Clinical nuclear medicine.
2014 Jan; 39(1):e53-8. doi:
10.1097/rlu.0b013e31829aface. [PMID: 23856824] - K Slavikova, F Montravers, G Treglia, J Kunikowska, L Kaliska, M Vereb, J N Talbot, S Balogova. What is currently the best radiopharmaceutical for the hybrid PET/CT detection of recurrent medullary thyroid carcinoma?.
Current radiopharmaceuticals.
2013 Jun; 6(2):96-105. doi:
10.2174/1874471011306020006. [PMID: 23745775] - Meng-Yao Lu, Yen-Lin Liu, Hsiu-Hao Chang, Shiann-Tarng Jou, Yung-Li Yang, Kai-Hsin Lin, Dong-Tsamn Lin, Ya-Ling Lee, Hsinyu Lee, Pei-Yi Wu, Tsai-Yueh Luo, Lie-Hang Shen, Shiu-Feng Huang, Yung-Feng Liao, Wen-Ming Hsu, Kai-Yuan Tzen. Characterization of neuroblastic tumors using 18F-FDOPA PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2013 Jan; 54(1):42-9. doi:
10.2967/jnumed.112.102772. [PMID: 23213196] - Giorgio Treglia, Fabrizio Cocciolillo, Francesco Di Nardo, Andrea Poscia, Chiara de Waure, Alessandro Giordano, Vittoria Rufini. Detection rate of recurrent medullary thyroid carcinoma using fluorine-18 dihydroxyphenylalanine positron emission tomography: a meta-analysis.
Academic radiology.
2012 Oct; 19(10):1290-9. doi:
10.1016/j.acra.2012.05.008. [PMID: 22819076] - Camilla Schalin-Jäntti, Aapo Ahonen, Marko Seppänen. 18F-DOPA PET/CT but not 68Ga-DOTA-TOC PET/CT revealed the underlying cause of ectopic Cushing syndrome.
Clinical nuclear medicine.
2012 Sep; 37(9):904-5. doi:
10.1097/rlu.0b013e318262adc7. [PMID: 22889786] - Giorgio Treglia, Paola Castaldi, Maria Felicia Villani, Germano Perotti, Chiara de Waure, Angelina Filice, Valentina Ambrosini, Nadia Cremonini, Monica Santimaria, Annibale Versari, Stefano Fanti, Alessandro Giordano, Vittoria Rufini. Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma.
European journal of nuclear medicine and molecular imaging.
2012 Apr; 39(4):569-80. doi:
10.1007/s00259-011-2031-6. [PMID: 22223169] - Allison B Weisbrod, Mio Kitano, Krisana Gesuwan, Corina Millo, Peter Herscovitch, Naris Nilubol, W Marston Linehan, Electron Kebebew. Clinical utility of functional imaging with ¹⁸F-FDOPA in Von Hippel-Lindau syndrome.
The Journal of clinical endocrinology and metabolism.
2012 Apr; 97(4):E613-7. doi:
10.1210/jc.2011-2626. [PMID: 22259055] - Stefanie D Krämer, Linjing Mu, Adrienne Müller, Claudia Keller, Olga F Kuznetsova, Christian Schweinsberg, Dominic Franck, Cristina Müller, Tobias L Ross, Roger Schibli, Simon M Ametamey. 5-(2-18F-fluoroethoxy)-L-tryptophan as a substrate of system L transport for tumor imaging by PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2012 Mar; 53(3):434-42. doi:
10.2967/jnumed.111.096289. [PMID: 22331220] - Lucia Martiniova, Susannah Cleary, Edwin W Lai, Dale O Kiesewetter, Jurgen Seidel, Linda F Dawson, Jacqueline K Phillips, David Thomasson, Xiaoyuan Chen, Graeme Eisenhofer, James F Powers, Richard Kvetnansky, Karel Pacak. Usefulness of [18F]-DA and [18F]-DOPA for PET imaging in a mouse model of pheochromocytoma.
Nuclear medicine and biology.
2012 Feb; 39(2):215-26. doi:
10.1016/j.nucmedbio.2011.07.007. [PMID: 21958851] - N Pavese, B S Simpson, V Metta, A Ramlackhansingh, K Ray Chaudhuri, D J Brooks. [¹⁸F]FDOPA uptake in the raphe nuclei complex reflects serotonin transporter availability. A combined [¹⁸F]FDOPA and [¹¹C]DASB PET study in Parkinson's disease.
NeuroImage.
2012 Jan; 59(2):1080-4. doi:
10.1016/j.neuroimage.2011.09.034. [PMID: 21963917] - Helle-Brit Fiebrich, Johan R de Jong, Ido P Kema, Klaas Pieter Koopmans, Wim Sluiter, Rudi A J O Dierckx, Annemiek M Walenkamp, Thera P Links, Adrienne H Brouwers, Elisabeth G E de Vries. Total 18F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour.
European journal of nuclear medicine and molecular imaging.
2011 Oct; 38(10):1854-61. doi:
10.1007/s00259-011-1862-5. [PMID: 21698413] - Daniel S Levine, Daniel L Metzger, Helen R Nadel, Angelica Oviedo, Michael J Adam, Erik Skarsgard. Novel use of F-DOPA PET/CT imaging in a child with paraganglioma/pheochromocytoma syndrome.
Pediatric radiology.
2011 Oct; 41(10):1321-5. doi:
10.1007/s00247-011-2109-0. [PMID: 21567141] - Marios Politis, Wolfgang H Oertel, Kit Wu, Niall P Quinn, Oliver Pogarell, David J Brooks, Anders Bjorklund, Olle Lindvall, Paola Piccini. Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio.
Movement disorders : official journal of the Movement Disorder Society.
2011 Sep; 26(11):1997-2003. doi:
10.1002/mds.23743. [PMID: 21611977] - Keisuke Matsubara, Hiroshi Watabe, Yoshitaka Kumakura, Takuya Hayashi, Christopher J Endres, Kotaro Minato, Hidehiro Iida. Sensitivity of kinetic macro parameters to changes in dopamine synthesis, storage, and metabolism: a simulation study for [¹⁸F]FDOPA PET by a model with detailed dopamine pathway.
Synapse (New York, N.Y.).
2011 Aug; 65(8):751-62. doi:
10.1002/syn.20899. [PMID: 21190220] - Yaping Chu, Jeffrey H Kordower. Lewy body pathology in fetal grafts.
Annals of the New York Academy of Sciences.
2010 Jan; 1184(?):55-67. doi:
10.1111/j.1749-6632.2009.05229.x. [PMID: 20146690] - Yoshitaka Kumakura, Paul Cumming. PET studies of cerebral levodopa metabolism: a review of clinical findings and modeling approaches.
The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
2009 Dec; 15(6):635-50. doi:
10.1177/1073858409338217. [PMID: 19793723] - Helle-Brit Fiebrich, Adrienne H Brouwers, Michiel N Kerstens, Milan E J Pijl, Ido P Kema, Johan R de Jong, Pieter L Jager, Philip H Elsinga, Rudi A J O Dierckx, Jacqueline E van der Wal, Wim J Sluiter, Elisabeth G E de Vries, Thera P Links. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.
The Journal of clinical endocrinology and metabolism.
2009 Oct; 94(10):3922-30. doi:
10.1210/jc.2009-1054. [PMID: 19622618] - Pekka Jokinen, Hans Helenius, Elina Rauhala, Anna Brück, Olli Eskola, Juha O Rinne. Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2009 Jun; 50(6):893-9. doi:
10.2967/jnumed.108.061572. [PMID: 19443601] - Mohsen Beheshti, Sigrid Pöcher, Reza Vali, Peter Waldenberger, Gabriele Broinger, Michael Nader, Susanne Kohlfürst, Christian Pirich, Henning Dralle, Werner Langsteger. The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT.
European radiology.
2009 Jun; 19(6):1425-34. doi:
10.1007/s00330-008-1280-7. [PMID: 19156423] - Alexander Haug, Christoph J Auernhammer, Björn Wängler, Reinhold Tiling, Gerwin Schmidt, Burkhard Göke, Peter Bartenstein, Gabriele Pöpperl. Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours.
European journal of nuclear medicine and molecular imaging.
2009 May; 36(5):765-70. doi:
10.1007/s00259-008-1030-8. [PMID: 19137293] - Karel Pacak, Graeme Eisenhofer, Ioannis Ilias. Diagnosis of pheochromocytoma with special emphasis on MEN2 syndrome.
Hormones (Athens, Greece).
2009 Apr; 8(2):111-6. doi:
10.14310/horm.2002.1227. [PMID: 19570738] - S A Eshuis, P L Jager, R P Maguire, S Jonkman, R A Dierckx, K L Leenders. Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson's disease and healthy controls.
European journal of nuclear medicine and molecular imaging.
2009 Mar; 36(3):454-62. doi:
10.1007/s00259-008-0989-5. [PMID: 19037637] - Olga T Hardy, Miguel Hernandez-Pampaloni, Janet R Saffer, Joshua S Scheuermann, Linda M Ernst, Richard Freifelder, Hongming Zhuang, Courtney MacMullen, Susan Becker, N Scott Adzick, Chaitanya Divgi, Abass Alavi, Charles A Stanley. Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism.
The Journal of clinical endocrinology and metabolism.
2007 Dec; 92(12):4706-11. doi:
10.1210/jc.2007-1637. [PMID: 17895314] - Thomas Siessmeier, Thorsten Kienast, Jana Wrase, Jennifer Lynne Larsen, Dieter F Braus, Michael N Smolka, Hans Georg Buchholz, Mathias Schreckenberger, Frank Rösch, Paul Cumming, Karl Mann, Peter Bartenstein, Andreas Heinz. Net influx of plasma 6-[18F]fluoro-L-DOPA (FDOPA) to the ventral striatum correlates with prefrontal processing of affective stimuli.
The European journal of neuroscience.
2006 Jul; 24(1):305-13. doi:
10.1111/j.1460-9568.2006.04903.x. [PMID: 16882026] - Vesna Sossi, Raúl de la Fuente-Fernández, Michael Schulzer, John Adams, Jon Stoessl. Age-related differences in levodopa dynamics in Parkinson's: implications for motor complications.
Brain : a journal of neurology.
2006 Apr; 129(Pt 4):1050-8. doi:
10.1093/brain/awl028. [PMID: 16476675] - Nathalie Boddaert, Maria Ribeiro, Guy Touati, Karine Mention, Vassili Valayanopoulos, Claire Nihoul-Fékété, Francis Brunelle, Pascale de Lonlay. [Radiological innovations in the screening and diagnosis of the inborn errors of metabolism].
Medecine sciences : M/S.
2005 Nov; 21(11):981-6. doi:
10.1051/medsci/20052111981. [PMID: 16274650] - Yoshitaka Kumakura, Ingo Vernaleken, Gerhard Gründer, Peter Bartenstein, Albert Gjedde, Paul Cumming. PET studies of net blood-brain clearance of FDOPA to human brain: age-dependent decline of [18F]fluorodopamine storage capacity.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
2005 Jul; 25(7):807-19. doi:
10.1038/sj.jcbfm.9600079. [PMID: 15729292] - I Brink, S Hoegerle, J Klisch, T A Bley. Imaging of pheochromocytoma and paraganglioma.
Familial cancer.
2005; 4(1):61-8. doi:
10.1007/s10689-004-2155-y. [PMID: 15883712] - Peter Brust, Gerd Vorwieger, Bernd Walter, Frank Füchtner, Holger Stark, Hiroto Kuwabara, Michael Herzau, Thomas Opfermann, Jörg Steinbach, Vadivel Ganapathy, Reinhard Bauer. The influx of neutral amino acids into the porcine brain during development: a positron emission tomography study.
Brain research. Developmental brain research.
2004 Sep; 152(2):241-53. doi:
10.1016/j.devbrainres.2004.07.002. [PMID: 15351512] - Peter Brust, Bernd Walter, Rainer Hinz, Frank Füchtner, Marco Müller, Jörg Steinbach, Reinhard Bauer. Developmental changes in the activities of aromatic amino acid decarboxylase and catechol-O-methyl transferase in the porcine brain: a positron emission tomography study.
Neuroscience letters.
2004 Jul; 364(3):159-63. doi:
10.1016/j.neulet.2004.04.041. [PMID: 15196667] - Basil A Eldadah, Karel Pacak, Graeme Eisenhofer, Courtney Holmes, Irwin J Kopin, David S Goldstein. Cardiac uptake-1 inhibition by high circulating norepinephrine levels in patients with pheochromocytoma.
Hypertension (Dallas, Tex. : 1979).
2004 Jun; 43(6):1227-32. doi:
10.1161/01.hyp.0000127305.87552.d6. [PMID: 15078865] - D J Brooks, K A Frey, K L Marek, D Oakes, D Paty, R Prentice, C W Shults, A J Stoessl. Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease.
Experimental neurology.
2003 Nov; 184 Suppl 1(?):S68-79. doi:
10.1016/j.expneurol.2003.08.008. [PMID: 14597329] - Walter Pirker. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?.
Movement disorders : official journal of the Movement Disorder Society.
2003 Oct; 18 Suppl 7(?):S43-51. doi:
10.1002/mds.10579. [PMID: 14531046] - Richard C Dodel, Helmut Höffken, J Carsten Möller, Bernhard Bornschein, Thomas Klockgether, Thomas Behr, Wolfgang H Oertel, Uwe Siebert. Dopamine transporter imaging and SPECT in diagnostic work-up of Parkinson's disease: a decision-analytic approach.
Movement disorders : official journal of the Movement Disorder Society.
2003 Oct; 18 Suppl 7(?):S52-62. doi:
10.1002/mds.10580. [PMID: 14531047] - Y Sharabi, S-T Li, R Dendi, C Holmes, D S Goldstein. Neurotransmitter specificity of sympathetic denervation in Parkinson's disease.
Neurology.
2003 Mar; 60(6):1036-9. doi:
10.1212/01.wnl.0000052690.91036.ff. [PMID: 12654979] - V Sossi, J E Holden, R de la Fuente-Fernandez, T J Ruth, A J Stoessl. Effect of dopamine loss and the metabolite 3-O-methyl-[18F]fluoro-dopa on the relation between the 18F-fluorodopa tissue input uptake rate constant Kocc and the [18F]fluorodopa plasma input uptake rate constant Ki.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
2003 Mar; 23(3):301-9. doi:
10.1097/01.wcb.0000050041.22945.3e. [PMID: 12621305] - K Marek, D Jennings, J Seibyl. Do dopamine agonists or levodopa modify Parkinson's disease progression?.
European journal of neurology.
2002 Nov; 9 Suppl 3(?):15-22. doi:
10.1046/j.1468-1331.9.s3.2.x. [PMID: 12464117] - Roberto Ceravolo, Paola Piccini, Dale L Bailey, Karin M Jorga, Helen Bryson, David J Brooks. 18F-dopa PET evidence that tolcapone acts as a central COMT inhibitor in Parkinson's disease.
Synapse (New York, N.Y.).
2002 Mar; 43(3):201-7. doi:
10.1002/syn.10034. [PMID: 11793426] - Vesna Sossi, Raúl de La Fuente-Fernández, James E Holden, Doris J Doudet, Jess McKenzie, A J Stoessl, T J Ruth. Increase in dopamine turnover occurs early in Parkinson's disease: evidence from a new modeling approach to PET 18 F-fluorodopa data.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
2002 Feb; 22(2):232-9. doi:
10.1097/00004647-200202000-00011. [PMID: 11823721] - T Poyot, F Condé, M C Grégoire, V Frouin, C Coulon, C Fuseau, F Hinnen, F Dollé, P Hantraye, M Bottlaender. Anatomic and biochemical correlates of the dopamine transporter ligand 11C-PE2I in normal and parkinsonian primates: comparison with 6-[18F]fluoro-L-dopa.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
2001 Jul; 21(7):782-92. doi:
10.1097/00004647-200107000-00003. [PMID: 11435790] - V Sossi, D J Doudet, J E Holden. A reversible tracer analysis approach to the study of effective dopamine turnover.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
2001 Apr; 21(4):469-76. doi:
10.1097/00004647-200104000-00015. [PMID: 11323532] - K Shoghi-Jadid, S C Huang, D B Stout, R E Yee, E L Yeh, K F Farahani, N Satyamurthy, M E Phelps, J R Barrio. Striatal kinetic modeling of FDOPA with a cerebellar-derived constraint on the distribution of volume of 30MFD: a PET investigation using non-human primates.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
2000 Jul; 20(7):1134-48. doi:
10.1097/00004647-200007000-00012. [PMID: 10908046] - P Cumming, F Yokoi, A Chen, P Deep, A Dagher, D Reutens, F Kapczinski, D F Wong, A Gjedde. Pharmacokinetics of radiotracers in human plasma during positron emission tomography.
Synapse (New York, N.Y.).
1999 Nov; 34(2):124-34. doi:
10.1002/(sici)1098-2396(199911)34:2<124::aid-syn5>3.0.co;2-o. [PMID: 10502311] - R Torstenson, J Tedroff, P Hartvig, K J Fasth, B Långström. A comparison of 11C-labeled L-DOPA and L-fluorodopa as positron emission tomography tracers for the presynaptic dopaminergic system.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
1999 Oct; 19(10):1142-9. doi:
10.1097/00004647-199910000-00011. [PMID: 10532639] - E H Danielsen, D F Smith, A D Gee, T K Venkatachalam, S B Hansen, F Hermansen, A Gjedde, P Cumming. Cerebral 6-[(18)F]fluoro-L-DOPA (FDOPA) metabolism in pig studied by positron emission tomography.
Synapse (New York, N.Y.).
1999 Sep; 33(4):247-58. doi:
10.1002/(sici)1098-2396(19990915)33:4<247::aid-syn1>3.0.co;2-6. [PMID: 10421705] - S C Huang, D B Stout, R E Yee, N Satyamurthy, J R Barrio. Distribution volume of radiolabeled large neutral amino acids in brain tissue.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
1998 Dec; 18(12):1288-93. doi:
10.1097/00004647-199812000-00002. [PMID: 9850140] - W D Brown, T R Oakes, O T DeJesus, M D Taylor, A D Roberts, R J Nickles, J E Holden. Fluorine-18-fluoro-L-DOPA dosimetry with carbidopa pretreatment.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
1998 Nov; 39(11):1884-91. doi:
NULL. [PMID: 9829576] - S A Rudnicki, S I Harik, M Dhodapkar, B Barlogie, D Eidelberg. Nervous system dysfunction in Waldenström's macroglobulinemia: response to treatment.
Neurology.
1998 Oct; 51(4):1210-3. doi:
10.1212/wnl.51.4.1210. [PMID: 9781565] - J Tiihonen, H Vilkman, P Räsänen, O P Ryynänen, H Hakko, J Bergman, T Hämäläinen, A Laakso, M Haaparanta-Solin, O Solin, M Kuoppamäki, E Syvälahti, J Hietala. Striatal presynaptic dopamine function in type 1 alcoholics measured with positron emission tomography.
Molecular psychiatry.
1998 Mar; 3(2):156-61. doi:
10.1038/sj.mp.4000365. [PMID: 9577840] - D B Stout, S C Huang, W P Melega, M J Raleigh, M E Phelps, J R Barrio. Effects of large neutral amino acid concentrations on 6-[F-18]Fluoro-L-DOPA kinetics.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
1998 Jan; 18(1):43-51. doi:
10.1097/00004647-199801000-00004. [PMID: 9428304] - P Deep, A Gjedde, P Cumming. On the accuracy of an [18F]FDOPA compartmental model: evidence for vesicular storage of [18F]fluorodopamine in vivo.
Journal of neuroscience methods.
1997 Oct; 76(2):157-65. doi:
10.1016/s0165-0270(97)00094-0. [PMID: 9350967] - J E Holden, D Doudet, C J Endres, G L Chan, K S Morrison, F J Vingerhoets, B J Snow, B D Pate, V Sossi, K R Buckley, T J Ruth. Graphical analysis of 6-fluoro-L-dopa trapping: effect of inhibition of catechol-O-methyltransferase.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
1997 Oct; 38(10):1568-74. doi:
NULL. [PMID: 9379194] - T Subramanian, D F Emerich, R A Bakay, J M Hoffman, M M Goodman, T M Shoup, G W Miller, A I Levey, G W Hubert, S Batchelor, S R Winn, J A Saydoff, R L Watts. Polymer-encapsulated PC-12 cells demonstrate high-affinity uptake of dopamine in vitro and 18F-Dopa uptake and metabolism after intracerebral implantation in nonhuman primates.
Cell transplantation.
1997 Sep; 6(5):469-77. doi:
10.1016/s0963-6897(97)00049-3. [PMID: 9331498] - M Psylla, I Günther, A Antonini, P Vontobel, H W Reist, A Zollinger, K L Leenders. Cerebral 6-[18F]fluoro-L-DOPA uptake in rhesus monkey: pharmacological influence of aromatic amino acid decarboxylase (AAAD) and catechol-O-methyltransferase (COMT) inhibition.
Brain research.
1997 Aug; 767(1):45-54. doi:
10.1016/s0006-8993(97)00552-0. [PMID: 9365014] - G Tissingh, P Bergmans, A Winogrodzka, J C Stoof, E C Wolters, J Booij, E A Van Royen. Nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
1997 Aug; 38(8):1271-2. doi:
NULL. [PMID: 9255164] - R F Wang, C Loc'h, B Mazière. Determination of unchanged [18F]dopamine in human and non-human primate plasma during positron emission tomography studies: a new solid-phase extraction method comparable to radio-thin-layer chromatography analysis.
Journal of chromatography. B, Biomedical sciences and applications.
1997 Jun; 693(2):265-70. doi:
10.1016/s0378-4347(97)00086-8. [PMID: 9210428] - O T DeJesus, C J Endres, S E Shelton, R J Nickles, J E Holden. Evaluation of fluorinated m-tyrosine analogs as PET imaging agents of dopamine nerve terminals: comparison with 6-fluoroDOPA.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
1997 Apr; 38(4):630-6. doi:
. [PMID: 9098215] - D S Goldstein, C Holmes. Metabolic fate of the sympathoneural imaging agent 6-[18F]fluorodopamine in humans.
Clinical and experimental hypertension (New York, N.Y. : 1993).
1997 Jan; 19(1-2):155-61. doi:
10.3109/10641969709080812. [PMID: 9028643] - T Ishikawa, V Dhawan, K Kazumata, T Chaly, F Mandel, J Neumeyer, C Margouleff, B Babchyck, I Zanzi, D Eidelberg. Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
1996 Nov; 37(11):1760-5. doi:
NULL. [PMID: 8917170] - T Ishikawa, V Dhawan, T Chaly, W Robeson, A Belakhlef, F Mandel, R Dahl, C Margouleff, D Eidelberg. Fluorodopa positron emission tomography with an inhibitor of catechol-O-methyltransferase: effect of the plasma 3-O-methyldopa fraction on data analysis.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
1996 Sep; 16(5):854-63. doi:
10.1097/00004647-199609000-00010. [PMID: 8784230] - T Hanakawa, H Fukuyama, I Akiguchi, M Kato, J Kimura, H Shibasaki. [A case of familial juvenile dystonia-parkinsonism: 18F-6-fluorodopa and 18F-fluoro-2-deoxyglucose PET study].
Rinsho shinkeigaku = Clinical neurology.
1996 May; 36(5):655-60. doi:
NULL. [PMID: 8905984] - K Ishiwata, M Shinoda, S Ishii, T Nozaki, M Senda. Synthesis and evaluation of an 18F-labeled dopa prodrug as a PET tracer for studying brain dopamine metabolism.
Nuclear medicine and biology.
1996 Apr; 23(3):295-301. doi:
10.1016/0969-8051(95)02083-7. [PMID: 8782240] - L Wahl, C Nahmias. Modeling of fluorine-18-6-fluoro-L-Dopa in humans.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
1996 Mar; 37(3):432-7. doi:
NULL. [PMID: 8772639] - F J Vingerhoets, M Schulzer, T J Ruth, J E Holden, B J Snow. Reproducibility and discriminating ability of fluorine-18-6-fluoro-L-Dopa PET in Parkinson's disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
1996 Mar; 37(3):421-6. doi:
NULL. [PMID: 8772636] - I Günther, M Psylla, G N Reddy, A Antonini, P Vontobel, H W Reist, A Zollinger, R J Nickles, H F Beer, P A Schubiger. Positron emission tomography in drug evaluation: influence of three different catechol-O-methyltransferase inhibitors on metabolism of [NCA] 6-[18F]fluoro-L-dopa in rhesus monkey.
Nuclear medicine and biology.
1995 Oct; 22(7):921-7. doi:
10.1016/0969-8051(95)00032-s. [PMID: 8547890] - P Cumming, A Ase, M Diksic, J Harrison, D Jolly, H Kuwabara, C Laliberté, A Gjedde. Metabolism and blood-brain clearance of L-3,4-dihydroxy-[3H]phenylalanine ([3H]DOPA) and 6-[18F]fluoro-L-DOPA in the rat.
Biochemical pharmacology.
1995 Sep; 50(7):943-6. doi:
10.1016/0006-2952(95)00216-m. [PMID: 7575677] - G L Chan, D J Doudet, T Dobko, K A Hewitt, P Schofield, B D Pate, T J Ruth. Routes of administration and effect of carbidopa pretreatment on 6-[18F]fluoro-L-dopa/PET scans in non-human primates.
Life sciences.
1995; 56(21):1759-66. doi:
10.1016/0024-3205(95)00147-x. [PMID: 7739350] - H M Ruottinen, J O Rinne, U H Ruotsalainen, J R Bergman, V J Oikonen, M T Haaparanta, O H Solin, A O Laihinen, U K Rinne. Striatal [18F]fluorodopa utilization after COMT inhibition with entacapone studied with PET in advanced Parkinson's disease.
Journal of neural transmission. Parkinson's disease and dementia section.
1995; 10(2-3):91-106. doi:
10.1007/bf02251225. [PMID: 9620057] - P Cumming, H Kuwabara, A Gjedde. A kinetic analysis of 6-[18F]fluoro-L-dihydroxyphenylalanine metabolism in the rat.
Journal of neurochemistry.
1994 Nov; 63(5):1675-82. doi:
10.1046/j.1471-4159.1994.63051675.x. [PMID: 7931323] - S Kaakkola, A Gordin, P T Männistö. General properties and clinical possibilities of new selective inhibitors of catechol O-methyltransferase.
General pharmacology.
1994 Sep; 25(5):813-24. doi:
10.1016/0306-3623(94)90082-5. [PMID: 7835624] - G V Sawle, D J Burn, P K Morrish, A A Lammertsma, B J Snow, S Luthra, S Osman, D J Brooks. The effect of entacapone (OR-611) on brain [18F]-6-L-fluorodopa metabolism: implications for levodopa therapy of Parkinson's disease.
Neurology.
1994 Jul; 44(7):1292-7. doi:
10.1212/wnl.44.7.1292. [PMID: 8035933] - L Wahl, R Chirakal, G Firnau, E S Garnett, C Nahmias. The distribution and kinetics of [18F]6-fluoro-3-O-methyl-L-dopa in the human brain.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
1994 Jul; 14(4):664-70. doi:
10.1038/jcbfm.1994.83. [PMID: 8014214] - S Takikawa, V Dhawan, T Chaly, W Robeson, R Dahl, I Zanzi, F Mandel, P Spetsieris, D Eidelberg. Input functions for 6-[fluorine-18]fluorodopa quantitation in parkinsonism: comparative studies and clinical correlations.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
1994 Jun; 35(6):955-63. doi:
NULL. [PMID: 8195882] - T Pauwels, S Dethy, S Goldman, M Monclus, A Luxen. Effect of catechol-O-methyl transferase inhibition on peripheral and central metabolism of 6-[18F]fluoro-L-dopa.
European journal of pharmacology.
1994 May; 257(1-2):53-8. doi:
10.1016/0014-2999(94)90693-9. [PMID: 8082707] - R S Miletich, G Comi, K Bankiewicz, R Plunkett, R Adams, G Di Chiro, I J Kopin. 6-[18F]fluoro-L-dihydroxyphenylalanine metabolism and positron emission tomography after catechol-O-methyltransferase inhibition in normal and hemiparkinsonian monkeys.
Brain research.
1993 Oct; 626(1-2):1-13. doi:
10.1016/0006-8993(93)90556-3. [PMID: 8281420] - J P Hammerstad, B D Pate, K A Hewitt, G L Chan, T J Ruth, D B Calne. The transport of L-6-fluorodopa and its metabolites from blood to cerebrospinal fluid and brain.
Annals of neurology.
1993 Oct; 34(4):603-8. doi:
10.1002/ana.410340415. [PMID: 8215248] - P Cumming, G C Léger, H Kuwabara, A Gjedde. Pharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
1993 Jul; 13(4):668-75. doi:
10.1038/jcbfm.1993.85. [PMID: 8314919] - M Guttman, G Léger, A Reches, A Evans, H Kuwabara, J M Cedarbaum, A Gjedde. Administration of the new COMT inhibitor OR-611 increases striatal uptake of fluorodopa.
Movement disorders : official journal of the Movement Disorder Society.
1993 Jul; 8(3):298-304. doi:
10.1002/mds.870080308. [PMID: 8341294] - M Cordes, B J Snow, S Morrison, V Sossi, T J Ruth, D B Calne. Parametric imaging of the rate constant Ki using [18Fluoro]-L-dopa positron emission tomography in progressive supranuclear palsy.
Neuroradiology.
1993; 35(6):404-9. doi:
10.1007/bf00602816. [PMID: 8377907] - D J Doudet, T G Aigner, C A McLellan, R M Cohen. Positron emission tomography with 18F-dopa: interpretation and biological correlates in nonhuman primates.
Psychiatry research.
1992 Nov; 45(3):153-68. doi:
10.1016/0925-4927(92)90023-w. [PMID: 1283014]